Metlife Inc  

(Public, NYSE:MET-A)   Watch this stock  
Find more results for MET-A
0.00 (0.00%)
May 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 25.19 - 25.35
52 week 22.76 - 25.55
Open 25.31
Vol / Avg. 26,088.00/42,318.00
Mkt cap 49.20B
P/E 5.42
Div/yield 0.40/6.32
EPS 4.67
Shares 0.00
Beta 0.05
Inst. own inf%
Jul 27, 2016
Q2 2016 Metlife Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 14, 2016
Metlife Inc Annual Shareholders Meeting - 11:30AM EDT - Add to calendar
Jun 1, 2016
Metlife Inc at Deutsche Bank Global Financial Services Conference - 8:00AM EDT - Add to calendar
May 5, 2016
Q1 2016 Metlife Inc Earnings Call - Webcast
May 4, 2016
Q1 2016 Metlife Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 11.90% 7.60%
Operating margin 17.47% 12.39%
EBITD margin - 13.13%
Return on average assets 0.98% 0.60%
Return on average equity 12.25% 7.36%
Employees 69,000 -
CDP Score - 98 B


1095 Avenue of the Americas
NEW YORK, NY 10036-6797
United States - Map
+1-212-5785500 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


MetLife, Inc. (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). Its Retail segment is organized into two businesses: Life & Other, and Annuities. Its Group, Voluntary & Worksite Benefits insurance products and services include life, dental, group short- and long-term disability, property and casualty, long-term care, accidental death and dismemberment, critical illness, vision, and accident and health coverages, as well as prepaid legal plans. Its Corporate Benefit Funding segment provides funding and financing solutions that help institutional customers manage liabilities primarily associated with their qualified, nonqualified and welfare employee benefit programs using a spectrum of life and annuity-based insurance and investment products.

Officers and directors

Steven A. Kandarian J.D. Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
John C. R. Hele Chief Financial Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Michel Khalaf President, EMEA
Age: 52
Bio & Compensation  - Reuters
Christopher G. Townsend President, Asia
Age: 47
Bio & Compensation  - Reuters
Frans Hijkoop Chief Human Resource Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Steven J. Goulart Executive Vice President, Chief Investment Officer
Age: 57
Bio & Compensation  - Reuters
Esther Lee Executive Vice President, Chief Marketing Officer
Age: 57
Bio & Compensation  - Reuters
Ricardo A. Anzaldua J.D. Executive Vice President, General Counsel
Age: 62
Bio & Compensation  - Reuters
Marlene Debel Executive Vice President, Chief Financial Officer of U.S
Bio & Compensation  - Reuters
Martin J. Lippert Executive Vice President, Head - Global Technology and Operations
Age: 56
Bio & Compensation  - Reuters